Ophthotech rebrands as Iveric as focus turns to retinal gene therapies

Ophthotech Corp. (NASDAQ:OPHT) changed its name and ticker to Iveric

Read the full 107 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE